CoreCap Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249 Sell
10
-10
-50% -$234 ﹤0.01% 2981
2026
Q1
$280 Hold
20
﹤0.01% 2725
2025
Q4
$225 Hold
20
﹤0.01% 2803
2025
Q3
$231 Hold
20
﹤0.01% 2658
2025
Q2
$245 Hold
20
﹤0.01% 2601
2025
Q1
$287 Hold
20
﹤0.01% 2822
2024
Q4
$318 Hold
20
﹤0.01% 2620
2024
Q3
$481 Hold
20
﹤0.01% 2371
2024
Q2
$398 Hold
20
﹤0.01% 1464
2024
Q1
$398 Buy
+20
New +$387 ﹤0.01% 2355
2022
Q4
$541 Buy
+20
New +$489 ﹤0.01% 2153
2022
Q3
Sell
-20
Closed -$1K 648
2022
Q2
$1K Buy
+20
New +$575 ﹤0.01% 1949
2022
Q1
Sell
-25
Closed -$1K 657
2021
Q4
$1K Buy
+25
New +$808 ﹤0.01% 2047

Other funds holding AVNS

CoreCap Advisors's AVNS Position: Q2 2026 in Review

CoreCap Advisors reduced its Avanos Medical (AVNS) stake by 50% in Q2 2026, selling an estimated $234 and leaving 10 shares worth $249. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

CoreCap Advisors first reported a position in AVNS in Q4 2021 and has held it in 13 quarters since. The position peaked at $1K in Q2 2022. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • CoreCap Advisors held 10 shares of Avanos Medical worth $249 as of Q2 2026.
  • CoreCap Advisors sold 10 Avanos Medical shares in Q2 2026, an estimated $234.
  • Avanos Medical made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2981 holding.
  • CoreCap Advisors first reported a position in Avanos Medical in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Avanos Medical position peaked at $1K in Q2 2022.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.